Europe Wearable Cardioverter Defibrillator Market

Europe Wearable Cardioverter Defibrillator Market Size (2024 to 2029)

The Wearable Cardioverter Defibrillator Market size in Europe is predicted to grow at a robust CAGR from 2024 to 2029.

The wearable cardioverter defibrillators market is expected to be fuelled by the proliferation of diseases, rapidly increasing advancements in the development of automated external defibrillators, and the growing geriatric population across the region. A wearable cardioverter defibrillator allows doctors to assess their long-term arrhythmic risk and make necessary preparations to avoid abrupt cardiac arrest and death; however, the rising number of individuals with cardiac illnesses and advances in cardiology are likely to be the primary growth drivers for the wearable cardioverter defibrillator during the forecast period. As a result, wearable cardioverter-defibrillator devices are becoming more common as they may be used. At the same time, a patient waits for an implanted one owing to surgical restrictions, and they reduce the chance of cardiac arrest. A patient with a recent myocardial infarction and left ventricular failure, for example, can utilize the device in an event when there is no clear need for installing implantable devices. 

 In addition, the growing investment in various healthcare programs funded by the government and other organizations such as the World Health Organization, the growing elderly population, changes in disease prevalence or incidence rate, and rising service costs are all significant factors driving the market growth. Increasing healthcare infrastructure in countries such as the UK, Germany, and Spain provides lucrative growth opportunities for new market entrants. Also, technological advancements in healthcare are most likely to increase the European regional market growth. Furthermore, the initiatives taken by the government for creating awareness among the people and conducting medical tourism in the region are expected to influence the market growth. Cardiovascular disease is the leading cause of mortality. As a result, many new firms are interested in investing in new technologies that will enable them to provide enhanced diagnostic and treatment alternatives. For example, the wearable cardioverter defibrillator has an external defibrillator attached to a vest that the patient wears. It is frequently used in patients to bridge the gap between the need for an implantable cardioverter-defibrillator and the availability of one (ICD).

The cardioverter-defibrillator is still relatively unknown in developing nations, which might be a stumbling block to the market's growth. Furthermore, in several low-income countries, there are no stringent criteria or regulations in place to assess the safety and quality of wearable cardioverter-defibrillators. Thus, the use of wearable cardioverter-defibrillators has been hampered even further by the lack of agreed standards.

This research report on the Europe Wearable Cardioverter Defibrillator Market has been segmented and sub-segmented into the following categories:

By Conditions:

• Peripartum Cardiomyopathy
• Congenital Heart Disease
• Inherited Arrhythmias

By End User:

• Hospitals
• Home Care Settings
• Cardiology Clinics

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the European Wearable Cardioverter Defibrillator Market is projected to account for a substantial global market share during the forecast period. The market growth is attributed to the well-established reimbursement policies, increasing awareness among the general population, and evolving healthcare expenditure in the region. The manufacturers in the region are increasing their adoption of these devices, and the growing geriatric population is projected to propel the market growth. In Europe, the UK drives the wearable cardioverter defibrillators market, holding the largest share of the market.

On the other hand, countries such as Germany, France, Spain, and Italy are likely to showcase a higher market share in the region during the forecast period. However, the UK is expected to contribute a significant share to the regional market growth in the coming years. Growing number of heart disease, high prevalence of cardiovascular diseases and improving healthcare infrastructure is most likely to increase the market growth.

KEY MARKET PLAYERS:

A few of the notable companies operating in the major European Wearable Cardioverter Defibrillator Market profiled in this report are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and Nihon Kohden Corporation (Japan).